Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance
The precise mechanism about drug resistance of cancer stem cells (CSCs) has not yet been completely understood. Based on the expression of CD44 and CD133, two well-recognized cell surface markers for CSC identification, we tried to separate HCT8 colorectal cancer cells into different subpopulations...
Saved in:
Main Authors: | Shinji Goto (Author), Tsuyoshi Kawabata (Author), Tao-Sheng Li (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
by: Borger Darrell R, et al.
Published: (2010) -
Expression of CD133 in various premalignant and proliferative lesions
by: Rahmi Amtha, et al.
Published: (2015) -
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells
by: Ade Kallas-Kivi, et al.
Published: (2016) -
Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression
by: Do Luong Huynh, et al.
Published: (2017) -
PHYSIOLOGICAL ROLE OF BONE MARROW ADULT STEM CELL CD133+
by: J. IRGASHEVA, et al.
Published: (2017)